TUNITAS THERAPEUTICS, INC.

Basic Information

409 Illinois Street
San Francisco, CA, -

http://www.tunitastherapeutics.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 829828149
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 8


  1. A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): The overall goal of this phase 2 SBIR proposal is to position our novel biologic GE2 for human clinical trials in allergic disease though the completion of critic ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma

    Amount: $3,000,000.00

    DESCRIPTION provided by applicant The overall goal of this phase SBIR proposal is to position our novel biologic GE for human clinical trials in allergic disease though the completion of critic ...

    SBIR Phase II 2013 Department of Health and Human Services National Institutes of Health
  3. A therapeutic Fc gamma Fel d1 chimeric protein vaccine to treat cat allergy

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): The overall goal of this phase 2 SBIR proposal is to develop and commercialize a novel biologic for allergen- specific immunotherapy as effective treatment for ca ...

    SBIR Phase II 2012 Department of Health and Human Services
  4. Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy

    Amount: $1,699,968.00

    DESCRIPTION (provided by applicant): The overall goal of this Phase 2 STTR is to develop and commercialize a novel approach for allergen specific immunotherapy as a treatment for severe food allergy. ...

    STTR Phase II 2012 Department of Health and Human Services
  5. A Human Fc Bifunctional Fusion Protein to Treat Severe Allergic Asthma

    Amount: $443,494.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to develop and commercialize a novel biologic therapy for the treatment of allergic disease and particularly allergic asthma. ...

    SBIR Phase I 2011 Department of Health and Human Services
  6. Allergen???Fc-gamma1 proteins to treat food allergy

    Amount: $172,386.00

    DESCRIPTION (provided by applicant): The goal of this proposal is to develop and commercialize a novel approach for allergen specific immunotherapy as treatment for severe food allergy. Food allergy ...

    STTR Phase I 2010 Department of Health and Human Services
  7. Cat allergen-human Fc-gamma1 chimeric proteins to treat cat allergy

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): The overall goal of this SBIR proposal is to develop and commercialize a new approach for allergen specific immunotherapy as treatment for cat allergy. This propo ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government